Amarin Corp Plc (AMRN)

[north40000]

Did you look at the Amarin patents relating to CVD treatnebt or the Reduce-It indication? Did you find claim(s) that embrace or comprise or include the Vascepa composition or manufacture within the capsule, with or without the actual capsule also recited in the claim(s)?

Tell JL and me what you found via a message, with copy and paste versions of the claims that you found. If you found no claims comprising a composition of matter or article of manufacture, tell us so. We will stop there for the moment.

I am going to assume you found the kind of claims I asked you to look for. Now I want you to read 35 USC 271(a).

When H enters the market sometime after today, particularly after mid-December 2022 with its generic Vascepa, tell us what you think Amarin will do, hypothetically speaking. How do you think that H escapes any charge of direct infringement in acting to bring its generic Vascepa to market?